JNM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


The Journal of Nuclear Medicine Vol. 39 No. 8 1433-1441
© 1998 by Society of Nuclear Medicine
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Apostolopoulos, D. J.
Right arrow Articles by Vassilakos, P. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Apostolopoulos, D. J.
Right arrow Articles by Vassilakos, P. J.

Technetium-99m-Tetrofosmin for Parathyroid Scintigraphy: Comparison to Thallium-Technetium Scanning

Dimitris J. Apostolopoulos, Evangelia Houstoulaki, Costas Giannakenas, Theodore Alexandrides, John Spiliotis, George Nikiforidis, John G. Vlachojannis and Pavlos J. Vassilakos

University of Patras Medical School, Patras; Departments of Nuclear Medicine, Endocrinology, Surgery, Medical Physics and Nephrology, Regional University Hospital of Patras, Patras, Greece

Correspondence: For correspondence or reprints contact: Dimitris J. Apostolopoulos, MD, Department of Nuclear Medicine, University of Patras Medical School, Regional University Hospital of Patras, Rion Patras 26500, Greece.

ABSTRACT

The efficacy of 99mTc-tetrofosmin for the detection of parathyroid lesions was investigated prospectively in patients with hyperparathyroidism referred for surgical treatment. Methods: Twenty-seven patients with primary and 18 with tertiary hyperparathyroidism were studied. Twelve patients had undergone one or more previous neck explorations. Static imaging with 201TI was performed first, immediately followed by a 30-min 99mTc-tetrofosmin dynamic study. Delayed views of up to 3 hr postinjection were also obtained. Technetium-99m-pertechnetate was used for thyroid delineation. The tetrofosmin/99mTc-pertechnetate subtraction scan (TF/TC), the single-tracer washout technique and the thallium/technetium subtraction (TL/TC) were compared. Quantification of relative uptakes of tracers in the thyroid and abnormal parathyroids was accomplished by measuring activity within regions of interest. Kinetics of tetrofosmin in the thyroid and abnormal parathyroids were studied by evaluating the plots of the parathyroid to thyroid ratios against time as well as by calculation of the half-clearance times from the slow component of the time-activity curves. Results: The overall sensitivity, specificity and accuracy of TF/TC and TL/TC were 76%, 92% and 83% and 52%, 85%and 65%, respectively. The respective sensitivities were 87% and 70% for adenomas and 72% and 46% for hyperplasia. The parathyroid-to-thyroid activity ratios of tetrofosmin were significantly higher than those of thallium (p < 0.001). The tetrofosmin single-tracer washout study was less accurate than the subtraction technique (overall sensitivity and specificity, 70% and 69%, respectively). The washout properties of tetrofosmin in abnormal parathyroids were not substantially different from those in the thyroid, with a few exceptions (p = 0.4). No correlation of half-clearance times with parathyroid size, degree of early uptake, parathyroid hormone levels or histology could be established. Comparing adenomas to hyperplasia in respect to tetrofosmin retention, a statistically significant difference was observed (p = 0.005). Conclusion: Technetium-99m-tetrofosmin is suitable for parathyroid imaging. The kinetic properties of this agent in parathyroid and thyroid tissues do not warrant differential washout protocols. The diagnostic impact of the observed difference in tetrofosmin kinetics between parathyroid adenomas and hyperplasia requires further investigation.

Key Words: parathyroid scintigraphy • technetium-99m-tetrofosmin • thallium-technetium subtraction scan • comparison




This article has been cited by other articles:


Home page
Br. J. Radiol.Home page
F Lumachi, A Tregnaghi, P Zucchetta, M C Marzola, D Cecchin, P Marchesi, F Fallo, and F Bui
Technetium-99m sestamibi scintigraphy and helical CT together in patients with primary hyperparathyroidism: a prospective clinical study
Br. J. Radiol., February 1, 2004; 77(914): 100 - 103.
[Abstract] [Full Text] [PDF]


Home page
JNMHome page
A. Spanu, A. Falchi, A. Manca, P. Marongiu, A. Cossu, N. Pisu, F. Chessa, S. Nuvoli, and G. Madeddu
The Usefulness of Neck Pinhole SPECT as a Complementary Tool to Planar Scintigraphy in Primary and Secondary Hyperparathyroidism
J. Nucl. Med., January 1, 2004; 45(1): 40 - 48.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
JOURNAL OF NUCLEAR MEDICINE TECHNOLOGY THE JOURNAL OF NUCLEAR MEDICINE
Copyright © 1998 by the Society of Nuclear Medicine.